Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...

Contrave and Zepbound are two U.S. Food and Drug Administration (FDA)-approved medications for weight loss when combined with diet and exercise. But each medication works in different ways in the body ...

Zepbound and Mounjaro are brand-name injections with the same active ingredient: tirzepatide. Neither Zepbound nor Mounjaro is available as a generic drug. However, various forms of compounded ...

Millions of Medicare beneficiaries will gain access to obesity drugs for the first time starting Wednesday under CMS’ ...

Zealthy announced today the launch of its enhanced virtual weight-loss care platform, designed to simplify access to provider-guided obesity treatment through integrated telehealth services, insurance ...

Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?

CHARLOTTE, N.C. (QUEEN CITY NEWS) — As the popularity of GLP-1 medications for weight loss continues to soar, experts in ...

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.

Thanks to the internet, getting GLP-1 drugs into the hands of customers desperate to lose weight is easier than ever, but ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

Zepbound (tirzepatide) is approved by the FDA for weight loss and weight management in adults with obesity or overweight, while Ozempic (semaglutide) is approved for other uses, including managing ...

A new Medicare pathway, the Medicare GLP-1 Bridge program, makes Lilly's obesity medicines – a daily pill or the number 1 most prescribed injectable – accessible to eligible Medicare Part D patients ...